Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Diseases, Interstitial | 10 | 2021 | 243 | 1.270 |
Why?
|
| Tomography, X-Ray Computed | 17 | 2021 | 2618 | 0.940 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 7 | 2021 | 180 | 0.870 |
Why?
|
| Radiography, Thoracic | 8 | 2018 | 320 | 0.790 |
Why?
|
| Connective Tissue Diseases | 6 | 2021 | 67 | 0.670 |
Why?
|
| Idiopathic Interstitial Pneumonias | 4 | 2018 | 28 | 0.610 |
Why?
|
| Medical Records | 1 | 2016 | 119 | 0.550 |
Why?
|
| Calcinosis | 1 | 2016 | 229 | 0.510 |
Why?
|
| Alveolitis, Extrinsic Allergic | 3 | 2017 | 39 | 0.410 |
Why?
|
| Coronary Artery Disease | 1 | 2016 | 357 | 0.410 |
Why?
|
| Autoimmune Diseases | 3 | 2017 | 244 | 0.360 |
Why?
|
| Burnout, Professional | 2 | 2022 | 95 | 0.350 |
Why?
|
| Radiology Information Systems | 2 | 2020 | 77 | 0.310 |
Why?
|
| Lung | 7 | 2021 | 1226 | 0.300 |
Why?
|
| Radiographic Image Enhancement | 8 | 2016 | 463 | 0.290 |
Why?
|
| Prevalence | 8 | 2022 | 1246 | 0.250 |
Why?
|
| Pulmonary Fibrosis | 3 | 2019 | 125 | 0.220 |
Why?
|
| Autoimmunity | 3 | 2018 | 161 | 0.200 |
Why?
|
| Job Satisfaction | 1 | 2022 | 73 | 0.200 |
Why?
|
| Inhalation Exposure | 1 | 2021 | 30 | 0.190 |
Why?
|
| Occupational Health | 1 | 2021 | 33 | 0.190 |
Why?
|
| Aged | 17 | 2021 | 18644 | 0.180 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 3 | 1992 | 468 | 0.180 |
Why?
|
| Occupational Exposure | 1 | 2021 | 81 | 0.180 |
Why?
|
| Computer-Assisted Instruction | 1 | 2020 | 43 | 0.180 |
Why?
|
| Middle Aged | 18 | 2021 | 25343 | 0.170 |
Why?
|
| Humans | 36 | 2022 | 87555 | 0.170 |
Why?
|
| Mediastinum | 1 | 2019 | 46 | 0.170 |
Why?
|
| Survival Analysis | 3 | 2017 | 1535 | 0.170 |
Why?
|
| Female | 21 | 2022 | 45191 | 0.160 |
Why?
|
| Free Radical Scavengers | 1 | 2018 | 59 | 0.150 |
Why?
|
| Bronchiectasis | 1 | 2017 | 14 | 0.150 |
Why?
|
| Radiology | 1 | 2020 | 197 | 0.150 |
Why?
|
| Acetylcysteine | 1 | 2018 | 69 | 0.150 |
Why?
|
| Diagnostic Errors | 2 | 2016 | 161 | 0.150 |
Why?
|
| Male | 19 | 2022 | 41502 | 0.150 |
Why?
|
| Pathology, Clinical | 1 | 2017 | 34 | 0.150 |
Why?
|
| Immunosuppressive Agents | 3 | 2016 | 984 | 0.140 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 1687 | 0.140 |
Why?
|
| Speech Recognition Software | 1 | 2016 | 4 | 0.140 |
Why?
|
| Medical Audit | 1 | 2016 | 39 | 0.140 |
Why?
|
| Peer Review | 1 | 2016 | 23 | 0.140 |
Why?
|
| Pulmonary Alveoli | 1 | 2016 | 71 | 0.140 |
Why?
|
| Azathioprine | 1 | 2016 | 125 | 0.140 |
Why?
|
| Radiology Department, Hospital | 1 | 2016 | 25 | 0.140 |
Why?
|
| Retrospective Studies | 9 | 2021 | 8713 | 0.130 |
Why?
|
| Lung Neoplasms | 5 | 1992 | 2308 | 0.130 |
Why?
|
| Hospitalization | 2 | 2018 | 858 | 0.130 |
Why?
|
| Lymph Nodes | 1 | 2019 | 546 | 0.130 |
Why?
|
| Carrier Proteins | 1 | 2018 | 677 | 0.130 |
Why?
|
| Guideline Adherence | 1 | 2016 | 225 | 0.130 |
Why?
|
| Sensitivity and Specificity | 5 | 2021 | 2016 | 0.120 |
Why?
|
| X-Ray Film | 2 | 1993 | 36 | 0.120 |
Why?
|
| Hematologic Neoplasms | 1 | 2017 | 334 | 0.120 |
Why?
|
| Diagnosis, Differential | 5 | 2018 | 1579 | 0.110 |
Why?
|
| Copying Processes | 1 | 1993 | 6 | 0.110 |
Why?
|
| Cohort Studies | 4 | 2021 | 2791 | 0.100 |
Why?
|
| Radiologists | 2 | 2022 | 45 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 1021 | 0.100 |
Why?
|
| Cardiomegaly | 1 | 1991 | 114 | 0.090 |
Why?
|
| Biopsy | 3 | 2021 | 1173 | 0.090 |
Why?
|
| Thoracic Vertebrae | 1 | 1989 | 50 | 0.080 |
Why?
|
| Reproducibility of Results | 3 | 2021 | 2734 | 0.080 |
Why?
|
| Antibodies, Antinuclear | 2 | 2018 | 82 | 0.080 |
Why?
|
| Respiratory Function Tests | 2 | 2018 | 138 | 0.080 |
Why?
|
| Heart | 1 | 1991 | 567 | 0.080 |
Why?
|
| Evaluation Studies as Topic | 3 | 1993 | 271 | 0.070 |
Why?
|
| Adult | 8 | 2018 | 26018 | 0.070 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 994 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2018 | 856 | 0.060 |
Why?
|
| Lung Diseases | 3 | 1991 | 266 | 0.060 |
Why?
|
| Survival Rate | 2 | 2019 | 1870 | 0.060 |
Why?
|
| Hypertension, Pulmonary | 2 | 2018 | 349 | 0.060 |
Why?
|
| Chronic Disease | 2 | 2017 | 942 | 0.060 |
Why?
|
| False Positive Reactions | 3 | 1992 | 222 | 0.060 |
Why?
|
| Surveys and Questionnaires | 2 | 2022 | 2556 | 0.060 |
Why?
|
| Registries | 2 | 2017 | 733 | 0.060 |
Why?
|
| United States | 3 | 2021 | 6769 | 0.050 |
Why?
|
| Phenotype | 2 | 2019 | 2415 | 0.050 |
Why?
|
| Personal Satisfaction | 1 | 2022 | 62 | 0.050 |
Why?
|
| Systematized Nomenclature of Medicine | 1 | 2020 | 2 | 0.050 |
Why?
|
| Prognosis | 2 | 2019 | 3708 | 0.050 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 1989 | 1096 | 0.040 |
Why?
|
| Radiography | 2 | 2020 | 810 | 0.040 |
Why?
|
| Propensity Score | 1 | 2018 | 140 | 0.040 |
Why?
|
| Observer Variation | 2 | 2017 | 607 | 0.040 |
Why?
|
| Cause of Death | 1 | 2018 | 269 | 0.040 |
Why?
|
| Pulmonary Diffusing Capacity | 1 | 2016 | 24 | 0.040 |
Why?
|
| Respiratory Tract Infections | 1 | 2017 | 107 | 0.040 |
Why?
|
| ROC Curve | 4 | 1991 | 768 | 0.040 |
Why?
|
| Vital Capacity | 1 | 2016 | 67 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2017 | 369 | 0.040 |
Why?
|
| Mycophenolic Acid | 1 | 2016 | 88 | 0.030 |
Why?
|
| Fibrosis | 1 | 2017 | 210 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2017 | 235 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2016 | 389 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 852 | 0.030 |
Why?
|
| Pulmonary Artery | 1 | 2017 | 312 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 1674 | 0.030 |
Why?
|
| Antigens | 1 | 2016 | 228 | 0.030 |
Why?
|
| Disease Progression | 1 | 2019 | 1473 | 0.030 |
Why?
|
| Logistic Models | 1 | 2018 | 1198 | 0.030 |
Why?
|
| Lung Transplantation | 1 | 2018 | 249 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 1031 | 0.030 |
Why?
|
| Solitary Pulmonary Nodule | 2 | 1992 | 139 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 426 | 0.030 |
Why?
|
| Environmental Exposure | 1 | 2016 | 311 | 0.030 |
Why?
|
| Comorbidity | 1 | 2017 | 933 | 0.030 |
Why?
|
| Biophysical Phenomena | 1 | 1993 | 123 | 0.030 |
Why?
|
| Lasers | 1 | 1993 | 106 | 0.030 |
Why?
|
| Biophysics | 1 | 1993 | 153 | 0.030 |
Why?
|
| Mass Chest X-Ray | 1 | 1992 | 5 | 0.030 |
Why?
|
| Ribs | 1 | 1992 | 45 | 0.030 |
Why?
|
| Chicago | 1 | 2017 | 1394 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 4232 | 0.030 |
Why?
|
| Filtration | 1 | 1992 | 25 | 0.030 |
Why?
|
| X-Ray Intensifying Screens | 1 | 1991 | 32 | 0.020 |
Why?
|
| Thoracic Diseases | 1 | 1991 | 25 | 0.020 |
Why?
|
| Foreign Bodies | 1 | 1991 | 64 | 0.020 |
Why?
|
| Whole-Body Counting | 1 | 1989 | 7 | 0.020 |
Why?
|
| Gallium Radioisotopes | 1 | 1989 | 31 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2017 | 2260 | 0.020 |
Why?
|
| Methods | 1 | 1989 | 152 | 0.020 |
Why?
|
| Spinal Neoplasms | 1 | 1989 | 48 | 0.020 |
Why?
|
| Child | 1 | 2020 | 7039 | 0.020 |
Why?
|
| Models, Neurological | 1 | 1990 | 406 | 0.020 |
Why?
|
| Models, Structural | 1 | 1987 | 58 | 0.020 |
Why?
|
| Time Factors | 1 | 2016 | 5262 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 1989 | 572 | 0.020 |
Why?
|
| Computer Simulation | 1 | 1990 | 1088 | 0.020 |
Why?
|
| Young Adult | 1 | 2017 | 6117 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 1989 | 1962 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 8054 | 0.010 |
Why?
|
| Japan | 1 | 1992 | 303 | 0.010 |
Why?
|
| Spectrum Analysis | 1 | 1991 | 118 | 0.010 |
Why?
|
| Decision Trees | 1 | 1990 | 59 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 1991 | 225 | 0.010 |
Why?
|
| Pneumothorax | 1 | 1991 | 53 | 0.010 |
Why?
|
| Radiation Dosage | 1 | 1991 | 226 | 0.010 |
Why?
|
| Equipment Design | 1 | 1991 | 411 | 0.010 |
Why?
|
| Mediastinal Neoplasms | 1 | 1989 | 47 | 0.010 |
Why?
|
| Radiography, Abdominal | 1 | 1989 | 68 | 0.010 |
Why?
|
| Pattern Recognition, Automated | 1 | 1990 | 218 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1989 | 221 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 1991 | 299 | 0.010 |
Why?
|
| Pilot Projects | 1 | 1990 | 855 | 0.000 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 1990 | 333 | 0.000 |
Why?
|
| Lymphatic Metastasis | 1 | 1989 | 498 | 0.000 |
Why?
|
| Neoplasm Metastasis | 1 | 1989 | 1092 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1989 | 6613 | 0.000 |
Why?
|